Effect of HIV infection on menstrual cycle length

Siobán D. Harlow, Paula Schuman, Mardge Cohen, Suzanne E. Ohmit, Susan Cu-Uvin, Xihong Lin, Kathryn Anastos, David Burns, Ruth Greenblatt, Howard Minkoff, Laila Muderspach, Ann Rompalo, Dora Warren, Mary A. Young, Robert S. Klein

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

HIV serostatus and menstrual function were examined using prospectively collected menstrual data from 802 HIV-seropositive and 273 HIV-seronegative women, ages 20 to 44, enrolled in two cohort studies of HIV infection in North American women. The associations between HIV serostatus and the probabilities of having a cycle lasting >40 days (n = 541 cycles), >90 days (n = 67 cycles), <18 days (n = 316 cycles) and mean length and variability of 18 to 40 day cycles (n = 3634) were assessed. After adjustment for demographic characteristics, body mass index, and substance use, seropositivity increased the odds of having a very short cycle (<18 days, odds ratio [OR], 1.45; 95% confidence interval [CI], 1.00-2.11) and a very long cycle (>90 days, OR, 1.32; 95% CI, 0.68-2.58) slightly, although the latter CIs include one. Seropositivity did not increase the odds of having a moderately long cycle (>40 days, OR, 1.14) or affect mean cycle length or variability (β, 0.30 ± 0.20; between-woman standard deviation [SD], 2.2 days [HIV-seronegative] and 1.9 days [HIV-seropositive]; within-woman SD, 3.5 days for both). Although seropositivity may slightly increase the probability of very short cycles, HIV serostatus has little overall effect on amenorrhea, menstrual cycle length, or variability. Among HIV-seropositive women, higher viral loads and lower CD4+ counts were associated with increased cycle variability and polymenorrhea.

Original languageEnglish (US)
Pages (from-to)68-75
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume24
Issue number1
StatePublished - May 1 2000
Externally publishedYes

Fingerprint

Menstrual Cycle
HIV Infections
HIV
Menstruation Disturbances
Amenorrhea
CD4 Lymphocyte Count
Viral Load
Cohort Studies

Keywords

  • Amenorrhea
  • HIV
  • Menstruation
  • Menstruation disorders

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Harlow, S. D., Schuman, P., Cohen, M., Ohmit, S. E., Cu-Uvin, S., Lin, X., ... Klein, R. S. (2000). Effect of HIV infection on menstrual cycle length. Journal of Acquired Immune Deficiency Syndromes, 24(1), 68-75.

Effect of HIV infection on menstrual cycle length. / Harlow, Siobán D.; Schuman, Paula; Cohen, Mardge; Ohmit, Suzanne E.; Cu-Uvin, Susan; Lin, Xihong; Anastos, Kathryn; Burns, David; Greenblatt, Ruth; Minkoff, Howard; Muderspach, Laila; Rompalo, Ann; Warren, Dora; Young, Mary A.; Klein, Robert S.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 24, No. 1, 01.05.2000, p. 68-75.

Research output: Contribution to journalArticle

Harlow, SD, Schuman, P, Cohen, M, Ohmit, SE, Cu-Uvin, S, Lin, X, Anastos, K, Burns, D, Greenblatt, R, Minkoff, H, Muderspach, L, Rompalo, A, Warren, D, Young, MA & Klein, RS 2000, 'Effect of HIV infection on menstrual cycle length', Journal of Acquired Immune Deficiency Syndromes, vol. 24, no. 1, pp. 68-75.
Harlow SD, Schuman P, Cohen M, Ohmit SE, Cu-Uvin S, Lin X et al. Effect of HIV infection on menstrual cycle length. Journal of Acquired Immune Deficiency Syndromes. 2000 May 1;24(1):68-75.
Harlow, Siobán D. ; Schuman, Paula ; Cohen, Mardge ; Ohmit, Suzanne E. ; Cu-Uvin, Susan ; Lin, Xihong ; Anastos, Kathryn ; Burns, David ; Greenblatt, Ruth ; Minkoff, Howard ; Muderspach, Laila ; Rompalo, Ann ; Warren, Dora ; Young, Mary A. ; Klein, Robert S. / Effect of HIV infection on menstrual cycle length. In: Journal of Acquired Immune Deficiency Syndromes. 2000 ; Vol. 24, No. 1. pp. 68-75.
@article{edfd398ccfb2410cb5509b26a10401e0,
title = "Effect of HIV infection on menstrual cycle length",
abstract = "HIV serostatus and menstrual function were examined using prospectively collected menstrual data from 802 HIV-seropositive and 273 HIV-seronegative women, ages 20 to 44, enrolled in two cohort studies of HIV infection in North American women. The associations between HIV serostatus and the probabilities of having a cycle lasting >40 days (n = 541 cycles), >90 days (n = 67 cycles), <18 days (n = 316 cycles) and mean length and variability of 18 to 40 day cycles (n = 3634) were assessed. After adjustment for demographic characteristics, body mass index, and substance use, seropositivity increased the odds of having a very short cycle (<18 days, odds ratio [OR], 1.45; 95{\%} confidence interval [CI], 1.00-2.11) and a very long cycle (>90 days, OR, 1.32; 95{\%} CI, 0.68-2.58) slightly, although the latter CIs include one. Seropositivity did not increase the odds of having a moderately long cycle (>40 days, OR, 1.14) or affect mean cycle length or variability (β, 0.30 ± 0.20; between-woman standard deviation [SD], 2.2 days [HIV-seronegative] and 1.9 days [HIV-seropositive]; within-woman SD, 3.5 days for both). Although seropositivity may slightly increase the probability of very short cycles, HIV serostatus has little overall effect on amenorrhea, menstrual cycle length, or variability. Among HIV-seropositive women, higher viral loads and lower CD4+ counts were associated with increased cycle variability and polymenorrhea.",
keywords = "Amenorrhea, HIV, Menstruation, Menstruation disorders",
author = "Harlow, {Siob{\'a}n D.} and Paula Schuman and Mardge Cohen and Ohmit, {Suzanne E.} and Susan Cu-Uvin and Xihong Lin and Kathryn Anastos and David Burns and Ruth Greenblatt and Howard Minkoff and Laila Muderspach and Ann Rompalo and Dora Warren and Young, {Mary A.} and Klein, {Robert S.}",
year = "2000",
month = "5",
day = "1",
language = "English (US)",
volume = "24",
pages = "68--75",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Effect of HIV infection on menstrual cycle length

AU - Harlow, Siobán D.

AU - Schuman, Paula

AU - Cohen, Mardge

AU - Ohmit, Suzanne E.

AU - Cu-Uvin, Susan

AU - Lin, Xihong

AU - Anastos, Kathryn

AU - Burns, David

AU - Greenblatt, Ruth

AU - Minkoff, Howard

AU - Muderspach, Laila

AU - Rompalo, Ann

AU - Warren, Dora

AU - Young, Mary A.

AU - Klein, Robert S.

PY - 2000/5/1

Y1 - 2000/5/1

N2 - HIV serostatus and menstrual function were examined using prospectively collected menstrual data from 802 HIV-seropositive and 273 HIV-seronegative women, ages 20 to 44, enrolled in two cohort studies of HIV infection in North American women. The associations between HIV serostatus and the probabilities of having a cycle lasting >40 days (n = 541 cycles), >90 days (n = 67 cycles), <18 days (n = 316 cycles) and mean length and variability of 18 to 40 day cycles (n = 3634) were assessed. After adjustment for demographic characteristics, body mass index, and substance use, seropositivity increased the odds of having a very short cycle (<18 days, odds ratio [OR], 1.45; 95% confidence interval [CI], 1.00-2.11) and a very long cycle (>90 days, OR, 1.32; 95% CI, 0.68-2.58) slightly, although the latter CIs include one. Seropositivity did not increase the odds of having a moderately long cycle (>40 days, OR, 1.14) or affect mean cycle length or variability (β, 0.30 ± 0.20; between-woman standard deviation [SD], 2.2 days [HIV-seronegative] and 1.9 days [HIV-seropositive]; within-woman SD, 3.5 days for both). Although seropositivity may slightly increase the probability of very short cycles, HIV serostatus has little overall effect on amenorrhea, menstrual cycle length, or variability. Among HIV-seropositive women, higher viral loads and lower CD4+ counts were associated with increased cycle variability and polymenorrhea.

AB - HIV serostatus and menstrual function were examined using prospectively collected menstrual data from 802 HIV-seropositive and 273 HIV-seronegative women, ages 20 to 44, enrolled in two cohort studies of HIV infection in North American women. The associations between HIV serostatus and the probabilities of having a cycle lasting >40 days (n = 541 cycles), >90 days (n = 67 cycles), <18 days (n = 316 cycles) and mean length and variability of 18 to 40 day cycles (n = 3634) were assessed. After adjustment for demographic characteristics, body mass index, and substance use, seropositivity increased the odds of having a very short cycle (<18 days, odds ratio [OR], 1.45; 95% confidence interval [CI], 1.00-2.11) and a very long cycle (>90 days, OR, 1.32; 95% CI, 0.68-2.58) slightly, although the latter CIs include one. Seropositivity did not increase the odds of having a moderately long cycle (>40 days, OR, 1.14) or affect mean cycle length or variability (β, 0.30 ± 0.20; between-woman standard deviation [SD], 2.2 days [HIV-seronegative] and 1.9 days [HIV-seropositive]; within-woman SD, 3.5 days for both). Although seropositivity may slightly increase the probability of very short cycles, HIV serostatus has little overall effect on amenorrhea, menstrual cycle length, or variability. Among HIV-seropositive women, higher viral loads and lower CD4+ counts were associated with increased cycle variability and polymenorrhea.

KW - Amenorrhea

KW - HIV

KW - Menstruation

KW - Menstruation disorders

UR - http://www.scopus.com/inward/record.url?scp=0006159589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0006159589&partnerID=8YFLogxK

M3 - Article

C2 - 10877498

AN - SCOPUS:0006159589

VL - 24

SP - 68

EP - 75

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -